Font Size: a A A
Keyword [Plasminogen activator inhibitor]
Result: 181 - 200 | Page: 10 of 10
181. Research Progress Of Plasminogen Activator Inhibitor One In Gestational Diabetes Mellitus
182. The Significance Of Intrapleural Pingyangmycin Administration On PAI-1,t-PA And TGF-β1 Of Malignant Pleural Effusion
183. The Comparision Of Therapeutic Effect Between Calcium Dobesilate And Perindopril On Early Diabetic Nephropathy Rat
184. Ⅰ.The Correlation Between Human Leukocyte Antigen G And Progesterone Receptor In Endometrial Adenocarcinoma Ⅱ.Mifepristone As Abortifacient Modulating The Expression Of Smad7
185. Effects And Mechanism Of Bezafibrate On Expression Of PAI-1 Induced By Ox-LDL In HUVECs
186. The Effects Of Benazepril On Thrombomoduline And Plasminogen Activator Inhibitor-1 In Diabetic Rats With Renal Lesions
187. Variations Of TF, ATⅢ, PAI-1 And APC% Levels In The Blood Of Patients With Severe Multiple-Trauma And Their Function To Prevent The Occurrence Of Pre-DIC
188. Association Of Genetic Polymorphisms In 5, 10-methylenetetrahydrofolate Reductase Gene, Plasminogen Activator Inhibitor-1 Gene With Preterm Birth And Spastic Cerebral Palsy
189. Effects Of Jiejufushenning On Expression Of Tumor Necrosis Factor-Alpha And Monocyte Chemoattractant Protein-1 And On Regulation Of PAI-1/tPA And TXB2/6-k-PGF1α In Rats Of Diabetic Nephropathy
190. Effect Of Ghrelin On CLP-induced ALI In Mice And The Signal Pathways Involved In The Modulation
191. Relations Of The Level Of Plasma PAI-1 With Urine Micro-albumin In Type 2 Diabetes Mellitus
192. Expression Of Tissue-type Plasminogen Activator And Plasminogen Activator Inhibitor In Kidney Of Diabetic Rats And Effect Of Cordyceps Sinensis
193. The Cardial Protective Effect Of Calcium Dobesilate On Diabetic Rats
194. A Study Of Correlation Between Diabetic Nephropathy And Plasminogen Activator Inhibitor-1, Adiponectin.
195. The Effects Of Spironolactone In Inhibiting Aldosterone Mediated Oxidative Stress And Plasminogen Activator Inhibitor-1 Expression Of Rat Glomerular Mesangial Cells In Vitro
196. Relationship Between Plasma Urokinase-type Plasminogen Activator(uPA) And Plasminogen Activator Inhibitor(PAI-1) Level And Biological Behaviors In The Breast Cancer Patients
197. The Study On Plasminogen Activator Inhibitor Type 1 And High-sensitive C-reactive Protein In Metabolic Syndrome With Coronary Heart Disease
198. The Relationship Between The Level Of Serum PAI-1 And The Development Of Collaterals In Patients With Coronary Artery Disease
199. Effects Of Simvastatin Pretreatment On Coagulation Function And C-reactive Protein Of Liver In Septic Rats
200. Effect Of Asymmetric Dimethylarginine On Fibrinolytic Factors And The Cellular Mechanismsin Vascular Endothelium
  <<First  <Prev  Next>  Last>>  Jump to